This point was a burning question but, with the time and release of new data, the debate is going to calm down as shown in the following presentations. However, there are still remaining points of debate: What is the exact risk of very late stent thrombosis? Does it exist a class effect meaning that all DES are equivalent? Is prolonged dual antiplatelet therapy the answer?
How to implement the question of DES safety in a multivessel multistenting procedure?
Multivessel disease (61 min.)
Speaker: G. Sianos, M. Van der Ent
The state of the art in terms of dual antiplatelet therapy after DES implantation(15 min.)
Speaker: J.-P. Bassand
The role of endothelium in DES safety: quantity and/or quality?
Endothelium after stenting: quality versus quantity
Speaker: R. Virmani
The recent data about long term evaluation of first generation DES
TAXUS VI. Outcomes in Complex Patients Treated with the TAXUS ExpressModerate Release (MR) Stent. Finall 5-Year Resullts
Speaker: K. Dawkins
Late Clinical Outcomes of Paclitaxel and Sirolimus-Eluting Coronary Stents in Diabetic Patients without STEMI: Results from the STENT Group
Speaker: T. Stuckey
Limitation of first generation drug-eluting stents
Speaker: E. Garcia
Current status DES : Safety & Efficacy :{Generation 2 versus Generation 1}
Speaker: T. Gershlick
Two-Year Clinical Outcomes After Implantation of Coronary Sirolimus-, Paclitaxel-eluting and Bare Metal Stents in Western Denmark
Speaker: A. Kaltoft
Long-term safety of DES
Speaker: M.B. Leon
Can we improve safety of DES using IVUS?
Long-term health outcome and mortality evaluation after invasive coronary treatment using drug-eluting stents with or without the IVUS guidance
Speaker: P. Cervinka
How to demonstrate the safety of new DES?
How to design clinical trials to evaluate long-term safety of DES
Speaker: E. Grube
Do new DES comers improve safety?
Are all new generation DES the same?
Speaker: S. Windecker
SPIRIT III - 2-year clinical follow-up results
Speaker: G.-W. Stone
NOBORI 1 long-term results
Speaker: B. Chevalier
Is still there a debate between BMS and DES? A plea for a selective use
DES should be used sparingly – only when necessary
Speaker: W. Wijns
What could be the future solution?
The future of DES technology
Speaker: P.-W. Serruys
